| Financial Year |
March 31 2023 |
| Monetary Funds |
31,777,126,584.59 |
| Held-for-trading Financial Assets |
1,462,644,163.74 |
| Notes Receivable |
-- |
| Accounts Receivable |
58,917,427.67 |
| Advances to Suppliers |
-- |
| Other Receivables |
12,503,235,135.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
7,776,312,442.53 |
| Dividend Receivable |
-- |
| Inventories |
10,625,047,835.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
964,128,821.76 |
| Total Current Assets |
59,395,495,360.50 |
| Available-for-Sale Financial Asset |
118,738,189,045.49 |
| Held-to-maturity Investments |
8,833,033,746.28 |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
10,175,712,830.08 |
| Investment Properties |
11,185,223,760.14 |
| Fixed Assetes |
674,019,741.56 |
| Under-construction Projects |
95,604,120.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
287,908,039.33 |
| R&D expenses |
-- |
| Goodwill |
6,192,211,156.66 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
2,040,773,092.56 |
| Other Non-Current Assets |
263,761,928.09 |
| Sub-Total of Non-Current Assets |
240,019,222,253.58 |
| Total Assets |
299,414,717,614.08 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
86,103,806.35 |
| Accounts Received In Advance |
42,654,239.85 |
| Employee Compensation Payable |
134,444,373.86 |
| Taxes Payable |
90,426,558.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,030,272,509.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
1,512,440,057.22 |
| Sub-Total of Current Liabilities |
23,862,680,227.94 |
| Long-term Loans |
1,302,810,000.00 |
| Bonds Payable |
5,510,000,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,348,104,373.42 |
| Other Non-Current Liabilities |
232,046,859,183.10 |
| Sub-Total of Non-Current Liabilities |
240,288,975,524.44 |
| Total Liabilities |
264,151,655,752.38 |
| Paid-In Capital(Or Share Stock) |
4,940,629,165.00 |
| Capital Surplus |
11,093,620,918.97 |
| Surplus Reserve |
274,250,562.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,553,752,046.70 |
| Minority Stockholder's Interest |
13,516,052,474.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,747,009,386.92 |
| Owner's Equity（Stockholder's Equity） |
35,263,061,861.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
299,414,717,614.08 |
